MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 188 filers reported holding MEDIVATION INC in Q2 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $19,892,000 | +31.1% | 329,876 | 0.0% | 0.21% | +30.6% |
| Q1 2016 | $15,168,000 | -52.4% | 329,876 | -50.0% | 0.16% | -39.4% |
| Q4 2015 | $31,892,000 | +13.7% | 659,752 | 0.0% | 0.26% | +1.9% |
| Q3 2015 | $28,039,000 | +10.3% | 659,752 | +65.6% | 0.26% | -27.7% |
| Q4 2013 | $25,421,000 | +6.5% | 398,331 | 0.0% | 0.36% | +5.6% |
| Q3 2013 | $23,876,000 | +21.8% | 398,331 | 0.0% | 0.34% | -12.6% |
| Q2 2013 | $19,598,000 | – | 398,331 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |